DalsnaFinance

Clinical Trial of Shigella Vaccine Shows 89% Protection

Markets PR Newswire By PR Newswire 01 Jul 2026 15:30 1 min read
Clinical Trial of Shigella Vaccine Shows 89% Protection

Cincinnati Children's researchers help lead study to combat disease that poses global health risk CINCINNATI, July 1, 2026 /PRNewswire/ --A new clinical trial involving researchers from Cincinnati Children's reports encouraging progress toward a long-sought vaccine against Shigella, a...

Cincinnati Children's researchers help lead study to combat disease that poses global health risk CINCINNATI, July 1, 2026 /PRNewswire/ --A new clinical trial involving researchers from Cincinnati Children's reports encouraging progress toward a long-sought vaccine against Shigella, a...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.